UA86413C2 - Сахарное покрытие и твердая дозированая форма, которая его содержит - Google Patents

Сахарное покрытие и твердая дозированая форма, которая его содержит

Info

Publication number
UA86413C2
UA86413C2 UAA200612933A UAA200612933A UA86413C2 UA 86413 C2 UA86413 C2 UA 86413C2 UA A200612933 A UAA200612933 A UA A200612933A UA A200612933 A UAA200612933 A UA A200612933A UA 86413 C2 UA86413 C2 UA 86413C2
Authority
UA
Ukraine
Prior art keywords
heading
solid dosage
normal
dosage form
form containing
Prior art date
Application number
UAA200612933A
Other languages
English (en)
Ukrainian (uk)
Inventor
Джон К. Кларк
Джон Дж. Мичелуччи
Дебора М. Шерман
Original Assignee
Уайет
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Уайет filed Critical Уайет
Publication of UA86413C2 publication Critical patent/UA86413C2/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/282Organic compounds, e.g. fats
    • A61K9/2826Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30Oestrogens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34Gestagens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Medicinal Preparation (AREA)
  • Paints Or Removers (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

Изобретение касается сахаросодержащей композиции, применяемой для нанесения покрытия на твердые врачебные формы терапевтических средств, твердой лекарственной формы, которая включает такое покрытие, и способа получения такой твердой лекарственной формы.
UAA200612933A 2004-06-07 2005-06-07 Сахарное покрытие и твердая дозированая форма, которая его содержит UA86413C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57766804P 2004-06-07 2004-06-07

Publications (1)

Publication Number Publication Date
UA86413C2 true UA86413C2 (ru) 2009-04-27

Family

ID=35351681

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200612933A UA86413C2 (ru) 2004-06-07 2005-06-07 Сахарное покрытие и твердая дозированая форма, которая его содержит

Country Status (23)

Country Link
US (2) US20050271724A1 (ru)
EP (1) EP1753407B1 (ru)
JP (1) JP5000509B2 (ru)
CN (1) CN101267809A (ru)
AR (1) AR049142A1 (ru)
AU (1) AU2005251793B2 (ru)
BR (1) BRPI0511663A (ru)
CA (1) CA2566771A1 (ru)
CR (1) CR8778A (ru)
EC (1) ECSP067049A (ru)
ES (1) ES2623363T3 (ru)
GT (1) GT200500141A (ru)
IL (1) IL179537A0 (ru)
MX (1) MXPA06014229A (ru)
NO (1) NO20070091L (ru)
NZ (1) NZ551676A (ru)
PA (1) PA8636001A1 (ru)
PE (1) PE20060245A1 (ru)
RU (1) RU2428178C2 (ru)
SV (1) SV2006002136A (ru)
TW (1) TW200602089A (ru)
UA (1) UA86413C2 (ru)
WO (1) WO2005120466A2 (ru)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0602397C1 (pt) * 2006-04-20 2009-11-24 Unicamp composições farmacêuticas para o tratamento das doenças gordurosas do fìgado, obesidade e demais doenças associadas à sìndrome metabólica e métodos de tratamento utilizando-se as referidas composições
JP5198001B2 (ja) * 2006-06-23 2013-05-15 武田薬品工業株式会社 安定化された固形製剤
EP2042164A4 (en) * 2006-06-23 2010-10-13 Takeda Pharmaceutical STABILIZED SOLID PREPARATION
WO2008013084A1 (fr) * 2006-07-25 2008-01-31 Kowa Company, Ltd. Préparation enrobée de sucre et son procédé de fabrication
EP2086550A2 (en) * 2006-11-29 2009-08-12 Wyeth Estrogen/ serm and estrogen/ progestin bi-layer tablets
JP2010515758A (ja) * 2007-01-12 2010-05-13 ワイス エルエルシー 錠剤中錠剤組成物
US20090012146A1 (en) * 2007-07-02 2009-01-08 Giridhar Reddy Buggana Solubility-enhanced pharmaceutical compositions comprising zafirlukast
US20090232897A1 (en) * 2008-03-14 2009-09-17 Bijayananda Sahoo Pharmaceutical compositions comprising conjugated estrogens
WO2009135067A1 (en) * 2008-05-01 2009-11-05 Wyeth Pharmaceutical polish formulations
US20090324714A1 (en) * 2008-06-27 2009-12-31 Wyeth Dual adhesive technology
CN101744725B (zh) * 2008-12-09 2013-04-17 北京华素制药股份有限公司 缓释微丸包衣生产工艺参数的优化方法
EP2375903A4 (en) * 2008-12-15 2012-09-19 Somnus Therapeutics Inc METHOD FOR TREATING SILENTNESS
RU2410100C2 (ru) * 2009-03-30 2011-01-27 Александр Владимирович Диковский Фармацевтическая композиция ингибитора протонной помпы и пребиотика для лечения язвенных поражений желудка и 12-перстной кишки
US20110052687A1 (en) * 2009-08-26 2011-03-03 Glenmark Generics Ltd Extended release pharmaceutical composition of paliperidone
MX2012003082A (es) * 2009-09-17 2012-04-19 Cadila Healthcare Ltd Composiciones farmaceuticas para reducir la absorcion rapida de la dosis inducida por el alcohol.
US8663671B2 (en) 2009-11-05 2014-03-04 Philip Morris Usa Inc. Methods and compositions for producing hydrogel capsules coated for low permeability and physical integrity
SG10201504529WA (en) * 2010-03-09 2015-07-30 Alkermes Pharma Ireland Ltd Alcohol Resistant Enteric Pharmaceutical Compositions
US9492395B2 (en) 2010-05-11 2016-11-15 Sensient Colors Llc Film coating composition and methods of making and using the same
PL2665477T3 (pl) * 2011-01-20 2016-05-31 Bionevia Pharmaceuticals Inc Kompozycje epalrestatu lub jego pochodnej o zmodyfikowanym uwalnianiu i sposoby ich stosowania
US8846089B2 (en) * 2011-06-03 2014-09-30 Wakunaga Pharmaceutical Co., Ltd. Sugar-coated preparation and production method for the same
CN103385876B (zh) * 2012-05-08 2016-01-13 四川滇虹医药开发有限公司 一种夫罗曲坦的药物组合物及其制备方法
FR2996128B1 (fr) * 2012-09-28 2015-01-02 Inneov Lab Utilisation d'une association de taurine ou un de ses derives, et d'extrait de raisins pour ameliorer la qualite des ongles.
CN103977427A (zh) * 2014-05-08 2014-08-13 王�琦 一种糖衣产气粉配方及其制备方法
JP6504163B2 (ja) * 2014-06-02 2019-04-24 ニプロ株式会社 レーザー印刷用錠剤及びその製造方法
US20170348243A1 (en) * 2015-01-01 2017-12-07 Ideal Cures Pvt. Ltd. Novel film coating composition
JP6737793B2 (ja) * 2015-01-29 2020-08-12 ノヴォ ノルディスク アー/エス 錠剤コアとポリビニルアルコールコーティングとを含む経口インスリン投与のための医薬組成物
RU2588840C1 (ru) * 2015-03-26 2016-07-10 Общество с ограниченной ответственностью ООО "ВАЛЕНТА-ИНТЕЛЛЕКТ" Таблетки кветиапина с пролонгированным высвобождением и способ их получения
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
KR102437953B1 (ko) * 2016-08-04 2022-08-29 비피에스아이 홀딩스, 엘엘씨. 삼키기 쉬운 코팅제 및 이로써 코팅된 기질
FR3069545B1 (fr) * 2017-07-27 2020-10-16 Soc Dexploitation De Produits Pour Les Industries Chimiques Seppic Composition d'enrobage exempte de dioxyde de titane
MX2019008440A (es) * 2019-07-15 2021-01-18 Dva Farma Mexicana S A De C V Composiciones de recubrimientos en pelicula para tabletas con brillantez incrementada, procedimiento de preparacion y aplicacion.

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2565115A (en) 1948-10-28 1951-08-21 Squibb & Sons Inc Method of obtaining a conjugated estrogen preparation
US2720483A (en) * 1951-02-21 1955-10-11 Olin Mathieson Method of obtaining a conjugatedestrogen preparation
US3487152A (en) * 1967-02-07 1969-12-30 Hoffmann La Roche Tablets containing 7 - chloro - 2 - methylamino - 5 - phenyl - 3h - 1,4 - benzodiazepine-4-oxide and conjugated estrogenic substances
JPS625910A (ja) * 1985-07-02 1987-01-12 Shin Etsu Chem Co Ltd 薄層糖衣錠の製造方法
US5210081A (en) 1992-02-26 1993-05-11 American Home Products Corporation Alkali metal 8,9-dehydroestrone sulfate esters
EP0716597A1 (en) * 1993-08-30 1996-06-19 Warner-Lambert Company Tablet coating based on a melt-spun mixture of a saccharide and apolymer
US5547948A (en) * 1995-01-17 1996-08-20 American Home Products Corporation Controlled release of steroids from sugar coatings
US5759577A (en) * 1995-01-17 1998-06-02 American Home Products Corporation Controlled release of steroids from sugar coatings
WO1997004752A1 (en) * 1995-07-26 1997-02-13 Duramed Pharmaceuticals, Inc. Pharmaceutical compositions of conjugated estrogens and methods for their use
US6248391B1 (en) * 1997-07-16 2001-06-19 Bpsi Holdings, Inc. Bright white film coatings and film coating compositions therefor
MXPA01009934A (es) * 1999-03-29 2002-06-21 American Home Prod Sistema de recubrimiento.
US6630166B1 (en) * 2001-02-12 2003-10-07 Watson Pharmaceuticals, Inc. Compositions for conjugated estrogens and associated methods
US20030070584A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
AU2003213337A1 (en) * 2002-03-14 2003-09-22 Daiichi Suntory Pharma Co., Ltd. Tablet containing pilsicainide hydrochloride (wet)

Also Published As

Publication number Publication date
AR049142A1 (es) 2006-06-28
AU2005251793B2 (en) 2010-07-15
RU2428178C2 (ru) 2011-09-10
ES2623363T3 (es) 2017-07-11
NZ551676A (en) 2010-11-26
MXPA06014229A (es) 2007-05-04
ECSP067049A (es) 2007-02-28
WO2005120466A3 (en) 2007-04-19
CR8778A (es) 2007-10-01
WO2005120466A2 (en) 2005-12-22
IL179537A0 (en) 2007-05-15
US20050271724A1 (en) 2005-12-08
NO20070091L (no) 2007-01-05
CA2566771A1 (en) 2005-12-22
RU2006140093A (ru) 2008-07-20
EP1753407B1 (en) 2017-03-08
PA8636001A1 (es) 2006-05-16
JP5000509B2 (ja) 2012-08-15
US20110136772A1 (en) 2011-06-09
PE20060245A1 (es) 2006-05-03
BRPI0511663A (pt) 2008-01-02
SV2006002136A (es) 2006-02-15
EP1753407A2 (en) 2007-02-21
AU2005251793A1 (en) 2005-12-22
GT200500141A (es) 2006-01-10
JP2008501803A (ja) 2008-01-24
TW200602089A (en) 2006-01-16
CN101267809A (zh) 2008-09-17

Similar Documents

Publication Publication Date Title
UA86413C2 (ru) Сахарное покрытие и твердая дозированая форма, которая его содержит
WO2004074244A3 (en) Pyrimidine compounds
TW200508214A (en) Novel compounds
WO2003095455A3 (en) Substituted pyrazolopyrimidines
WO2005004818A3 (en) Heterocyclic compounds and their use as anticancer agents
WO2004033418A3 (en) Sulfonylamino-acetic derivatives and their use as orexin receptor antagonists
TW200604179A (en) Pyrazole derivatives, compositions containing such compounds and methods of use
CA2514473A1 (en) Fused bicyclic nitrogen-containing heterocycles
EP1140840A4 (en) DIPHENYLUREA WITH SUBSTITUENTS -G (V) -CARBOXYARYLES, INHIBITORS OF RAF KINASE
TNSN07161A1 (en) Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
TW200505837A (en) Novel compounds
TW200519075A (en) Novel compounds
WO2004112719A3 (en) Chemical compounds
TW200738659A (en) Novel compounds
NO20062824L (no) 1,3-Difenylprop-2-en-1-on-avledete forbindelser, fremgangsmater for fremstilling derav, samt anvendelse av samme
TW200514772A (en) Novel tetrahydropyridine derivatives
WO2004026836A3 (en) 1-pyridin-4-yl-urea derivatives
TW200745044A (en) Pyrazole derivatives, compositions containing such compounds and methods of use
TWI268278B (en) 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses
TW200508197A (en) Indolone-acetamide derivatives, processes for preparing them and their uses
TW200621773A (en) Bicyclononene derivatives
WO2006044753A3 (en) Chemical compounds
AU2003217712A1 (en) Pyrazolopyrimidine and pyrazolotriazine derivatives and pharmaceutical compositions containing them
WO2002070464A3 (en) Hydrazones and their therapeutic use
WO2005030209A8 (en) Pyridine derivatives and use thereof as urotensin ii antagonists